Peter Goldman and Joshua Raskin Join Board of Directors
Peter Goldman
Joshua Raskin
NEW
YORK and MIAMI,
The Parkinson's Foundation today announced the election of Chicago entrepreneur Peter
Goldman and New York financial analyst Joshua Raskin to
its Board of Directors.
"Peter and Joshua bring valuable business and philanthropic
experience that will further advance the Parkinson's Foundation's mission to
serve the one million Americans and ten million people worldwide living with
this disease," said John W. Kozyak, Esq., Chairman of the Board of
the Parkinson's Foundation.
Peter Goldman
Goldman is managing partner of Lakeshore Sport & Fitness in Chicago, which owns and operates businesses in the Chicago area focused on hospitality, health and wellness. Before becoming an entrepreneur, Goldman worked for Sam Zell in real estate investing and McKinsey & Company as a management consultant. He has served on several non-profit boards including the Auxiliary Board of the Art Institute of Chicago, where he was a vice president and created a new annual signature fundraising event.
Goldman is managing partner of Lakeshore Sport & Fitness in Chicago, which owns and operates businesses in the Chicago area focused on hospitality, health and wellness. Before becoming an entrepreneur, Goldman worked for Sam Zell in real estate investing and McKinsey & Company as a management consultant. He has served on several non-profit boards including the Auxiliary Board of the Art Institute of Chicago, where he was a vice president and created a new annual signature fundraising event.
"I am excited to join the Parkinson's Foundation board at
this critical time," Goldman said. "The Parkinson's Foundation's
mission to make life better for people with Parkinson's is more urgent than
ever with 60,000 new cases being diagnosed every year."
Joshua Raskin
For the past 18 years, Raskin has served as managing director at Barclay's Capital, where he coordinates coverage of the healthcare services sector in the equity research department. Prior to this, he was a managing director at Lehman Brothers for nine years. In 2017, Raskin formed Nephron Research, an independent research boutique focused on healthcare. He has a personal connection to Parkinson's in his immediate family.
For the past 18 years, Raskin has served as managing director at Barclay's Capital, where he coordinates coverage of the healthcare services sector in the equity research department. Prior to this, he was a managing director at Lehman Brothers for nine years. In 2017, Raskin formed Nephron Research, an independent research boutique focused on healthcare. He has a personal connection to Parkinson's in his immediate family.
"The fight against Parkinson's disease and the mission of
finding a cure are of deep importance to me, particularly in light of my family
history," Raskin said. "I remain committed to the Parkinson's
community in my new role on the Parkinson's Foundation board of
directors."
A complete list of the Parkinson's Foundation's Board of
Directors is available at www.parkinson.org/board.
About the Parkinson's Foundation
The Parkinson's Foundation makes life better for people with Parkinson's disease by improving care and advancing research toward a cure. In everything we do, we build on the energy, experience, and passion of our global Parkinson's community. For more information, visit www.parkinson.org or call (800) 4PD-INFO (473-4636).
The Parkinson's Foundation makes life better for people with Parkinson's disease by improving care and advancing research toward a cure. In everything we do, we build on the energy, experience, and passion of our global Parkinson's community. For more information, visit www.parkinson.org or call (800) 4PD-INFO (473-4636).
About Parkinson's Disease
Affecting an estimated one million Americans and 10 million worldwide, Parkinson's disease is the second-most common neurodegenerative disease after Alzheimer's and is the 14th-leading cause of death in the United States. It is associated with a progressive loss of motor control (e.g., shaking or tremor at rest and lack of facial expression), as well as non-motor symptoms (e.g., depression and anxiety). There is no cure for Parkinson's and 60,000 new cases are diagnosed each year in the United States alone.
Affecting an estimated one million Americans and 10 million worldwide, Parkinson's disease is the second-most common neurodegenerative disease after Alzheimer's and is the 14th-leading cause of death in the United States. It is associated with a progressive loss of motor control (e.g., shaking or tremor at rest and lack of facial expression), as well as non-motor symptoms (e.g., depression and anxiety). There is no cure for Parkinson's and 60,000 new cases are diagnosed each year in the United States alone.
Contact: Leilani Pearl, 305-537-9907, lpearl@parkinson.org
SOURCE Parkinson's Foundation
Related Links
https://www.prnewswire.com/news-releases/parkinsons-foundation-welcomes-two-new-board-members-300542094.html
No comments:
Post a Comment